$RYBullishLow

Here’s What Analysts Are Saying About Royal Bank of Canada (RY) Post Q1

CIBC raised its Royal Bank of Canada (RY) price target to C$279 from C$258 while keeping a Neutral rating, and Barclays lifted its target to C$260 from C$245 with an Overweight rating, both dated May 29. The updates followed RBC’s fiscal Q1 2026 results (quarter ended April 30), when net income rose to $5.5B (+25%) and diluted EPS to $3.85 (+27%).

Low
Bullish
After-hours/next-session read-through following May 29 analyst updates tied to May 28 Q1 results.
Generally supportive (target increases) with mixed rating stance (Neutral vs Overweight).

Post-Q1, multiple analysts lifted price targets while keeping ratings at Neutral/Overweight, reinforcing a constructive but not unanimous stance.

Royal Bank of Canada’s Q1 2026 results were followed by analyst target raises from CIBC and Barclays on May 29.

Mild upward bias for near-term positioning as target revisions may support sentiment, but magnitude likely limited without new earnings surprise beyond the already-reported quarter.

Background

The piece summarizes RBC’s fiscal Q1 2026 performance (quarter ended April 30) and subsequent analyst rating/target updates from CIBC and Barclays.

Why it matters

Target hikes after a strong quarter can support marginal buyers, but mixed rating language implies the market may already be pricing the earnings strength.

Market relevance

Near-term sentiment support for RY from multiple target increases, anchored to reported Q1 growth in net income and EPS.

Market effects

Signals continued analyst comfort with large Canadian bank earnings momentum, potentially supporting the broader banking read-across.

May modestly influence sentiment toward North American financials given the RBC-centric analyst revisions.

Limited; the story is company-specific and does not introduce cross-border regulatory or macro shocks.

Alternative perspectives

Neutral rating from CIBC alongside target increases suggests upside may be capped unless operating trends accelerate further.

The article provides earnings growth figures but does not discuss credit quality, NIM, or guidance—key drivers that could dominate price action after the initial reaction.

Key entities

  • Royal Bank of Canada

    Subject of the article; Q1 2026 results and subsequent analyst target/rating updates.

  • CIBC

    Raised RBC price target to C$279 from C$258; maintained Neutral.

  • Barclays

    Raised RBC price target to C$260 from C$245; maintained Overweight.

Related articles

$RYMed

Barclays Lifts PT on Royal Bank of Canada (RY) Following Q1 Results

Barclays raised its price target on Royal Bank of Canada (RY) to C$260 from C$245 and kept an Overweight rating after Royal Bank of Canada reported fiscal Q1 2026 results on May 28. The bank said adjusted earnings beat expectations, supported by stronger-than-expected fee income. For the quarter ended April 30, 2026, net income rose to $5.5B and diluted EPS to $3.85.

$SSRMMed

Wednesday’s analyst upgrades and downgrades

RBC Capital Markets raised its gold forecasts, citing new highs in 2026: $4,600/oz (+17%), $5,100/oz for 2027 (+24%) and long-term $3,000/oz (+15%). It also lifted silver and copper assumptions and adjusted stock targets. SSR Mining was upgraded to “outperform” with a $40 target. Desjardins shifted Canadian banks to “market weight,” raising TD and RBC targets.

$DSGXLow

Tech Stocks Rise Sharply, Limit Canadian Market's Downside

Canada’s S&P/TSX Composite fell 0.33% to 34,655.36 as U.S.-Iran peace-deal uncertainty rose after reports Iran may stop communicating with the U.S. and close the Strait of Hormuz. Oil jumped on U.S. strikes, lifting energy and tech; the IT Capped Index rose ~5.5% (Coveo +13.2%, Docebo ~+10%). Manufacturing PMI stayed in growth at 52.9.

$RYMed

12 Undervalued Financial Stocks to Buy Now

The article highlights 12 “undervalued” financial stocks, arguing the sector’s uneven performance amid credit, rates, and growth concerns has created valuation gaps. It cites Fidelity, T. Rowe Price, and J.P. Morgan Asset Management views on value outperformance and capital markets activity. For Royal Bank of Canada, BofA raised its target to C$273 (Buy) and Raymond James cut to Market Perform (C$265.50). For TD, BofA lifted to C$168 (Buy) and Raymond James upgraded to Outperform (C$152.50).

$RYLow

Brokerages Set Royal Bank Of Canada (NYSE:RY) Price Target at $162.00

MarketBeat reports that 14 brokerages rate Royal Bank of Canada (NYSE:RY) a consensus “Moderate Buy,” with 10 “buy” and four “hold” ratings. The average 12-month price target is $162.00. The article also cites RBC’s May 28 results: $2.84 EPS vs $2.81 expected, and $12.84B revenue vs $12.74B. RBC raised its quarterly dividend to $1.76/share.

$RYMed

Royal Bank (RY) Q2 2026 Earnings Transcript

Royal Bank of Canada reported Q2 2026 net income of $5.5 billion ($5.6 billion adjusted), with adjusted EPS of $3.90, up 25%, citing 11% revenue growth and over 3% all-bank operating leverage. Capital Markets net income was a record $1.5 billion; Wealth Management was $1.2 billion. Provisions were $899 million. Management said credit uncertainty increased and gross impaired loans rose $623 million.